Winfred
Back to Investors
LL

Lyva Labs

Other

Portfolio

2

companies

Portfolio companies

SP

Spotlight Pathology

Spotlight Pathology develops artificial intelligence tools to speed up blood cancer diagnosis.

CP

CCI Photonics

CCI Photonics develops rapid diagnostic devices for infectious diseases.

Recent investments

£425K

Spotlight Pathology raises £425k led by EHE Ventures to advance AI diagnostic tools

AI/MLHealthTech

EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.

"Spotlight Pathology represents exactly the type of highly innovative company that Deepbridge is privileged to invest in. We initially supported the team through our Seed Enterprise Investment Scheme (SEIS), and are now pleased to back them again through our EIS fund, alongside EHE and Lyva Labs. We look forward to supporting the team as they scale in the exciting field of digital pathology."
— Andrew Round, Investment Director
SP
Spotlight Pathology— United Kingdom
EHE Ventures
Deepbridge Capital
LL
EHE Ventures + 2 others
Seed
£450K

CCI Photonics secures £450k to develop rapid diagnostic technology

AI/MLBioTechMedTech

The funding was backed by investors including Lyva Labs and the Northern Powerhouse Investment Fund II.

"This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges. The collaboration between Lancaster University and Morecambe Bay NHS Foundation Trust laid the foundation for this innovation."
— Carlos Alejandro Meza Ramirez, CEO
CP
CCI Photonics— Lancaster, UK
NP
II
LL
Northern Powerhouse Investment Fund II + 2 others